Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Dow
Mallinckrodt
McKinsey
Argus Health
Deloitte
Harvard Business School
Federal Trade Commission

Generated: June 18, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: nalbuphine hydrochloride

« Back to Dashboard

nalbuphine hydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Hospira NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070914 ANDA Hospira, Inc. N 0409-1463-49
Hospira NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070914 ANDA Hospira, Inc. N 0409-1463-01
Hospira NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070914 ANDA General Injectables & Vaccines, Inc N 52584-463-01
Hospira NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070915 ANDA Hospira, Inc. N 0409-1464-01
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
Accenture
Daiichi Sankyo
Cerilliant
Citi
US Department of Justice
Federal Trade Commission
Queensland Health